Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Pre-Surgery Technique May Make Colostomy Bags Redundant

By HospiMedica International staff writers
Posted on 15 Jun 2016
Endoluminal stenting to unblock the bowel before surgery could lead to fewer emergency bowel cancer patients needing a colostomy bag, according to a new study.

Researchers at the Manchester Royal Infirmary (MRI, United Kingdom), the University of Oxford (United Kingdom), and other institutions conducted a study involving 246 patients presenting in the emergency setting with left-sided colonic obstruction needing urgent decompression, and radiological features of a carcinoma. More...
Patients were randomized to endoluminal stenting as a bridge to elective surgery performed 1-4 weeks later, or to surgical decompression.

The results showed that 30-day post-operative mortality and length of hospital stay were similar with stenting and surgery. But while 69% of the emergency surgical decompression patients needed a colostomy bag, only 45% of the endoluminal stenting as a bridge to surgery needed one. Stenting also achieved relief of obstruction in 82% of patients and reduced stoma formation; there were no significant differences in one-year mortality between groups. The study was presented at the American Society of Clinical Oncology (ASCO) cancer conference, held during June 2016 in Chicago (IL, USA).

“Traditionally, doctors have worried that unblocking the bowel in this way could increase the chance of cancer spreading, but our early results don’t show this. We’re also pleased to see that this could be a way of reducing the risk of patients needing a colostomy bag after their surgery, which is a huge improvement to patients’ day-to-day lives,” said lead author Professor James Hill, of the MRI. “These are early results, and we’ll need to follow-up our work for three years in full to find out if this technique affects survival and end-of-life care for bowel cancer patients.”

“This treatment isn’t suitable for everyone, but for those who are it could have a huge impact on their lives after surgery. Not needing a colostomy bag is likely to significantly improve the quality of life of patients,” added Martin Ledwick, head information nurse of Cancer Research UK (London). “If longer term follow-up and larger studies confirm these results, it is great news for bowel cancer patients who come to A&E with bowel blockages.”

A colostomy is an artificial opening (stoma) created surgically in the large intestine that allows the removal of feces out of the body, bypassing the rectum, to drain into a removable pouching system (the colostomy bag) that collects and contains the output for later disposal.

Related Links:
Manchester Royal Infirmary
University of Oxford
Cancer Research UK

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.